people are talking about a possible buyout today, who could it be? pfizer?..that would make sense..right? i mean zyvox patent runs out next year i think so that would open it up to generics. since our antibiotic works just as well with less sides, that would be a great candidate to launch a new product that can compete against their old generic. i mean, so far zyvox has been a blockbuster so wouldnt they want to protect that market share when patent runs out? i mean, thats my guess. anyone?